Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancerJ.-Y. Douillard, R. Sidhu, Salvatore Siena et al.|Annals of Oncology|2014Cited by 603
Activity of gemcitabine in patients with non-small cell lung cancer: A multicentre, extended phase II studyU. Gatzemeier, Maurizio Voi, R. Rosso et al.|European Journal of Cancer|1996Cited by 242
ALK-Rearranged Non–Small-Cell Lung Cancer Is Associated With a High Rate of Venous ThromboembolismAlona Zer, Frances A. Shepherd, Mor Moskovitz et al.|Clinical Lung Cancer|2016Cited by 100